• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

迂曲波浪状瘤内壁征是少突胶质细胞瘤敏感且特异的影像学生物标志物。

The sinuous, wave-like intratumoral-wall sign is a sensitive and specific radiological biomarker for oligodendrogliomas.

机构信息

Department of Neurosurgical Oncology, Beijing Tiantan Hospital, Capital Medical University, China National Clinical Research Center for Neurological Diseases, Beijing Neurosurgical Institute, Beijing, 100070, China.

Department of Neurosurgery, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China.

出版信息

Eur Radiol. 2023 Jun;33(6):4440-4452. doi: 10.1007/s00330-022-09314-0. Epub 2022 Dec 15.

DOI:10.1007/s00330-022-09314-0
PMID:36520179
Abstract

OBJECTIVES

The purpose of this study was to investigate the clinical utility of the sinuous, wave-like intratumoral-wall (SWITW) sign on T2WI in diagnosing isocitrate dehydrogenase (IDH) mutant and 1p/19q codeleted (IDHmut-Codel) oligodendrogliomas, for which a relatively conservative resection strategy might be sufficient due to a better response to chemoradiotherapy and favorable prognosis.

METHODS

Imaging data from consecutive adult patients with diffuse lower-grade gliomas (LGGs, histological grades 2-3) in Beijing Tiantan Hospital (December 1, 2013, to October 31, 2021, BTH set, n = 711) and the Cancer Imaging Archive (TCIA) LGGs set (n = 117) were used to develop and validate our findings. Two independent observers assessed the SWITW sign and some well-reported discriminative radiological features to establish a practical diagnostic strategy.

RESULTS

The SWITW sign showed satisfying sensitivity (0.684 and 0.722 for BTH and TCIA sets) and specificity (0.938 and 0.914 for BTH and TCIA sets) in defining IDHmut-Codels, and the interobserver agreement was substantial (κ 0.718 and 0.756 for BTH and TCIA sets). Compared to calcification, the SWITW sign improved the sensitivity by 0.28 (0.404 to 0.684) in the BTH set, and 81.0% (277/342) of IDHmut-Codel cases demonstrated SWITW and/ or calcification positivity. Combining the SWITW sign, calcification, low ADC values, and other discriminative features, we established a concise and reliable diagnostic protocol for IDHmut-Codels.

CONCLUSIONS

The SWITW sign was a sensitive and specific imaging biomarker for IDHmut-Codels. The integrated protocol provided an explicable, efficient, and reproducible method for precise preoperative diagnosis, which was essential to guide individualized surgical plan-making.

KEY POINTS

• The SWITW sign was a sensitive and specific imaging biomarker for IDHmut-Codel oligodendrogliomas. • The SWITW sign was more sensitive than calcification and an integrated strategy could improve diagnostic sensitivity for IDHmut-Codel oligodendrogliomas. • Combining SWITW, calcification, low ADC values, and other discriminative features could make a precise preoperative diagnosis for IDHmut-Codel oligodendrogliomas.

摘要

目的

本研究旨在探讨 T2WI 上肿瘤内迂曲波浪状壁(SWITW)征对异柠檬酸脱氢酶(IDH)突变和 1p/19q 共缺失(IDHmut-Codel)少突胶质细胞瘤的临床应用价值,对于这些肿瘤,由于对放化疗反应良好且预后较好,因此相对保守的切除策略可能就足够了。

方法

本研究使用了来自北京天坛医院(2013 年 12 月 1 日至 2021 年 10 月 31 日,BTH 组,n = 711)和癌症影像档案(TCIA)低级别胶质瘤(LGG)组(n = 117)的连续成人弥漫性低级别胶质瘤(LGG,组织学 2-3 级)患者的影像学数据来开发和验证我们的研究结果。两位独立的观察者评估了 SWITW 征和一些公认的有鉴别意义的影像学特征,以建立一种实用的诊断策略。

结果

SWITW 征在定义 IDHmut-Codel 方面具有令人满意的敏感性(BTH 和 TCIA 组分别为 0.684 和 0.722)和特异性(BTH 和 TCIA 组分别为 0.938 和 0.914),观察者间的一致性较高(BTH 和 TCIA 组的κ 值分别为 0.718 和 0.756)。与钙化相比,SWITW 征在 BTH 组中提高了 0.28 的敏感性(从 0.404 提高到 0.684),并且 81.0%(277/342)的 IDHmut-Codel 病例表现出 SWITW 和/或钙化阳性。结合 SWITW 征、钙化、低 ADC 值和其他有鉴别意义的特征,我们建立了一个简明可靠的 IDHmut-Codel 诊断方案。

结论

SWITW 征是 IDHmut-Codel 少突胶质细胞瘤的一种敏感且特异的影像学生物标志物。综合方案为精确的术前诊断提供了一种可解释、高效和可重复的方法,这对于指导个体化手术方案的制定至关重要。

重点

  1. SWITW 征是 IDHmut-Codel 少突胶质细胞瘤的一种敏感且特异的影像学生物标志物。

  2. SWITW 征比钙化更敏感,综合策略可以提高 IDHmut-Codel 少突胶质细胞瘤的诊断敏感性。

  3. 结合 SWITW、钙化、低 ADC 值和其他有鉴别意义的特征,可以对 IDHmut-Codel 少突胶质细胞瘤进行精确的术前诊断。

相似文献

1
The sinuous, wave-like intratumoral-wall sign is a sensitive and specific radiological biomarker for oligodendrogliomas.迂曲波浪状瘤内壁征是少突胶质细胞瘤敏感且特异的影像学生物标志物。
Eur Radiol. 2023 Jun;33(6):4440-4452. doi: 10.1007/s00330-022-09314-0. Epub 2022 Dec 15.
2
Combining hyperintense FLAIR rim and radiological features in identifying IDH mutant 1p/19q non-codeleted lower-grade glioma.联合 FLAIR 环征高信号和影像学特征识别 IDH 突变 1p/19q 非共缺失低级别胶质瘤。
Eur Radiol. 2022 Jun;32(6):3869-3879. doi: 10.1007/s00330-021-08500-w. Epub 2022 Jan 25.
3
The T2-FLAIR-mismatch sign as an imaging biomarker for IDH and 1p/19q status in diffuse low-grade gliomas: a systematic review with a Bayesian approach to evaluation of diagnostic test performance.T2-FLAIR 错配征象作为弥漫性低级别胶质瘤 IDH 和 1p/19q 状态的影像学生物标志物:一项基于贝叶斯方法评估诊断试验性能的系统评价。
Neurosurg Focus. 2019 Dec 1;47(6):E13. doi: 10.3171/2019.9.FOCUS19660.
4
Advanced imaging parameters improve the prediction of diffuse lower-grade gliomas subtype, IDH mutant with no 1p19q codeletion: added value to the T2/FLAIR mismatch sign.高级影像学参数可提高弥漫性低级别胶质瘤 IDH 突变型无 1p19q 联合缺失亚型的预测准确性:T2/FLAIR 不匹配征象的附加价值。
Eur Radiol. 2020 Feb;30(2):844-854. doi: 10.1007/s00330-019-06395-2. Epub 2019 Aug 24.
5
Radiogenomic association between the T2-FLAIR mismatch sign and IDH mutation status in adult patients with lower-grade gliomas: an updated systematic review and meta-analysis.成人低级别胶质瘤患者 T2-FLAIR 不匹配征象与 IDH 突变状态的放射基因组关联:一项更新的系统评价和荟萃分析。
Eur Radiol. 2022 Aug;32(8):5339-5352. doi: 10.1007/s00330-022-08607-8. Epub 2022 Feb 15.
6
Predicting 1p/19q codeletion status using diffusion-, susceptibility-, perfusion-weighted, and conventional MRI in IDH-mutant lower-grade gliomas.使用弥散加权成像、磁敏感加权成像、灌注加权成像和常规 MRI 预测 IDH 突变型低级别胶质瘤的 1p/19q 共缺失状态。
Acta Radiol. 2021 Dec;62(12):1657-1665. doi: 10.1177/0284185120973624. Epub 2020 Nov 22.
7
Improving Noninvasive Classification of Molecular Subtypes of Adult Gliomas With Diffusion-Weighted MR Imaging: An Externally Validated Machine Learning Algorithm.利用扩散加权磁共振成像提高成人脑胶质瘤分子亚型的无创分类:一种经过外部验证的机器学习算法。
J Magn Reson Imaging. 2023 Oct;58(4):1234-1242. doi: 10.1002/jmri.28630. Epub 2023 Feb 2.
8
Radiomic features from dynamic susceptibility contrast perfusion-weighted imaging improve the three-class prediction of molecular subtypes in patients with adult diffuse gliomas.动态磁敏感对比灌注加权成像的放射组学特征可改善成人弥漫性胶质瘤患者分子亚型的三分类预测。
Eur Radiol. 2023 May;33(5):3455-3466. doi: 10.1007/s00330-023-09459-6. Epub 2023 Feb 28.
9
Cortical high-flow sign on arterial spin labeling: a novel biomarker for IDH-mutation and 1p/19q-codeletion status in diffuse gliomas without intense contrast enhancement.动脉自旋标记法显示的皮质高血流信号:弥漫性胶质瘤中异柠檬酸脱氢酶(IDH)突变和1p/19q共缺失状态的一种新型生物标志物,无明显对比增强。
Neuroradiology. 2023 Sep;65(9):1415-1418. doi: 10.1007/s00234-023-03186-x. Epub 2023 Jun 27.
10
IDH mutation, 1p19q codeletion and ATRX loss in WHO grade II gliomas.世界卫生组织二级胶质瘤中的异柠檬酸脱氢酶(IDH)突变、1p19q共缺失和α-地中海贫血/智力发育障碍综合征X连锁基因(ATRX)缺失
Oncotarget. 2015 Oct 6;6(30):30295-305. doi: 10.18632/oncotarget.4497.

引用本文的文献

1
Advanced MRI, Radiomics and Radiogenomics in Unravelling Incidental Glioma Grading and Genetic Status: Where Are We?高级磁共振成像、影像组学和放射基因组学在解读偶然发现的胶质瘤分级和基因状态中的应用:我们目前的进展如何?
Medicina (Kaunas). 2025 Aug 12;61(8):1453. doi: 10.3390/medicina61081453.
2
Establishment and validation of a nomogram for predicting IDH-wildtype glioblastomas in nonenhancing adult-type diffuse gliomas.预测非强化型成人型弥漫性胶质瘤中异柠檬酸脱氢酶野生型胶质母细胞瘤的列线图的建立与验证
Neurooncol Adv. 2025 Feb 8;7(1):vdaf035. doi: 10.1093/noajnl/vdaf035. eCollection 2025 Jan-Dec.
3
Advances in diffuse glial tumors diagnosis.

本文引用的文献

1
Improving the noninvasive classification of glioma genetic subtype with deep learning and diffusion-weighted imaging.利用深度学习和弥散加权成像提高脑胶质瘤遗传亚型的无创分类。
Neuro Oncol. 2022 Apr 1;24(4):639-652. doi: 10.1093/neuonc/noab238.
2
Reproducible imaging-based prediction of molecular subtype and risk stratification of gliomas across different experience levels using a structured reporting system.基于可重复成像的预测,使用结构化报告系统在不同经验水平下对脑胶质瘤的分子亚型和风险分层进行预测。
Eur Radiol. 2021 Oct;31(10):7374-7385. doi: 10.1007/s00330-021-08015-4. Epub 2021 Aug 10.
3
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary.
弥漫性神经胶质瘤的诊断进展。
Arq Neuropsiquiatr. 2023 Dec;81(12):1134-1145. doi: 10.1055/s-0043-1777729. Epub 2023 Dec 29.
2021 年世卫组织中枢神经系统肿瘤分类:概述。
Neuro Oncol. 2021 Aug 2;23(8):1231-1251. doi: 10.1093/neuonc/noab106.
4
Combining MGMT promoter pyrosequencing and protein expression to optimize prognosis stratification in glioblastoma.联合 MGMT 启动子焦磷酸测序和蛋白表达优化胶质母细胞瘤的预后分层。
Cancer Sci. 2021 Sep;112(9):3699-3710. doi: 10.1111/cas.15024. Epub 2021 Jul 2.
5
Distinguishing Pseudoprogression From True Early Progression in Isocitrate Dehydrogenase Wild-Type Glioblastoma by Interrogating Clinical, Radiological, and Molecular Features.通过分析临床、影像学和分子特征鉴别异柠檬酸脱氢酶野生型胶质母细胞瘤中的假性进展与真正早期进展
Front Oncol. 2021 Apr 20;11:627325. doi: 10.3389/fonc.2021.627325. eCollection 2021.
6
Differences in spatial distribution between WHO 2016 low-grade glioma molecular subgroups.世界卫生组织2016年低级别胶质瘤分子亚组之间的空间分布差异。
Neurooncol Adv. 2019 May 31;1(1):vdz001. doi: 10.1093/noajnl/vdz001. eCollection 2019 May-Dec.
7
MGMT promoter methylation is associated with patient age and 1p/19q status in IDH-mutant gliomas.在异柠檬酸脱氢酶(IDH)突变型胶质瘤中,O6-甲基鸟嘌呤-DNA甲基转移酶(MGMT)启动子甲基化与患者年龄及1p/19q状态相关。
Neuro Oncol. 2021 May 5;23(5):858-860. doi: 10.1093/neuonc/noab039.
8
The Role of Surgery in IDH-Wild-Type Lower-Grade Gliomas: Threshold at a High Extent of Resection Should be Pursued.手术在 IDH 野生型低级别胶质瘤中的作用:应追求高切除程度的阈值。
Neurosurgery. 2021 May 13;88(6):1136-1144. doi: 10.1093/neuros/nyab052.
9
IDH-Mutant Low-grade Glioma: Advances in Molecular Diagnosis, Management, and Future Directions.伴 IDH 突变的低级别胶质瘤:分子诊断、治疗进展和未来方向。
Curr Oncol Rep. 2021 Jan 25;23(2):20. doi: 10.1007/s11912-020-01006-6.
10
Extent of Resection of Glioblastoma: A Critical Evaluation in the Molecular Era.胶质母细胞瘤的切除术范围:分子时代的关键评估。
Neurosurg Clin N Am. 2021 Jan;32(1):23-29. doi: 10.1016/j.nec.2020.09.006. Epub 2020 Nov 5.